John Hunter Peel Alexander

Thrombin Time Vascular Surgical Procedures Far East Sodium Chloride Organ Preservation Solutions Ventricular Fibrillation Young Adult Warfarin Vena Cava Filters Ventricular Dysfunction, Left Venous Thromboembolism Vasoconstrictor Agents Veins World Health Wounds and Injuries Ticlopidine Tissue Plasminogen Activator Treatment Outcome Transfection Thrombosis Treatment Failure Transplantation, Autologous Troponin Urinary Bladder Diseases Vascular Diseases Troponin I Troponin T Tunica Intima Thromboplastin Time Factors United States Vascular Patency Tissue and Organ Harvesting Transplants Syndrome Shock, Cardiogenic Thromboembolism Stroke Tandem Mass Spectrometry Sucralfate Streptokinase Surgical Procedures, Operative Signal Transduction Statistics Stents Surgical Wound Infection Thrombolytic Therapy Survival Rate Thrombin Survival Analysis Survival Tachycardia, Ventricular Research Design Sensitivity and Specificity Registries Renin-Angiotensin System Rupture, Spontaneous Reoperation Risk Factors Risk Reduction Behavior Regression Analysis Risk Retrospective Studies Regional Blood Flow Risk Assessment Sex Distribution Sex Factors Severity of Illness Index Reproducibility of Results Reference Values Recurrence Pyridines Protein Binding Pyridones Pyridazines Pyrazoles Protein Precursors Quality Assurance, Health Care Prothrombin Surveys and Questionnaires Publication Bias Pulmonary Disease, Chronic Obstructive Protective Agents Pyridoxal Phosphate Recombinant Proteins Protein Isoforms Postoperative Care Probability Premedication Predictive Value of Tests Proportional Hazards Models Prognosis Prosthesis Design Postoperative Hemorrhage Postoperative Period Point-of-Care Systems Polysaccharides Practice Guidelines as Topic Prospective Studies Postoperative Complications Percutaneous Coronary Intervention Placebo Effect Pilot Projects Placebos Perioperative Care Platelet Factor 4 Physicians Practice Patterns, Physicians' Platelet Aggregation Inhibitors Pharmacokinetics Pericardial Effusion Physical Examination Peripheral Vascular Diseases Nitric Oxide Synthase New Zealand Neoplasms Peptide Fragments Myocardium Myocardial Ischemia Myoblasts, Skeletal North Carolina omega-N-Methylarginine Oligonucleotides Patient Selection Obesity Peptides Partial Thromboplastin Time Myocardial Revascularization Odds Ratio Naphthalenes Patient Readmission Medical Staff, Hospital Multicenter Studies as Topic Medication Errors Meta-Analysis Mineralocorticoid Receptor Antagonists Medicare Isoenzymes Middle Aged Mitral Valve Insufficiency Monitoring, Physiologic Kaplan-Meier Estimate Lidocaine Mortality Models, Theoretical Male Kidney Diseases Longitudinal Studies Injections, Subcutaneous Hypoglycemic Agents Internal Medicine Ischemia International Cooperation Hyperplasia Humans Immunoglobulin Fab Fragments International Normalized Ratio Hypertension Intracranial Hemorrhages Immunoprecipitation Incidence Hydrazones Infusions, Intravenous Injections, Intravenous Intraoperative Care Graft Occlusion, Vascular Hospitals, University Heparin, Low-Molecular-Weight Heart Valve Diseases Hospitalization Heart Valve Prosthesis Implantation Graft Rejection Hemorrhage Heart Diseases Heart Valve Prosthesis Heart Block Heart Defects, Congenital Glycated Hemoglobin A Hemodynamics Health Services Accessibility Guideline Adherence Graft Survival Heart Failure Health Plan Implementation Heparin Female European Continental Ancestry Group Genetic Predisposition to Disease Genetic Therapy Europe Genetic Engineering Fibrinolytic Agents Exercise Test Factor Xa Factor IXa Equipment Design Evidence-Based Medicine Feasibility Studies Factor IX Fibrin Fibrinogen Degradation Products Gastrointestinal Diseases Genotype Epitopes Follow-Up Studies Endoscopy Electrocardiography E2F Transcription Factors Electrophoresis, Polyacrylamide Gel Drug Toxicity Enoxaparin Electric Countershock Education, Medical, Continuing Enzyme Inhibitors Enzyme-Linked Immunosorbent Assay Endothelium, Vascular Echocardiography Drug Therapy, Combination Embolism Drug Prescriptions Disease-Free Survival Drug Combinations Drug Design Data Interpretation, Statistical Diabetes Mellitus Dose-Response Relationship, Drug Drug Administration Schedule DNA Creatine Kinase, MB Form Defibrillators, Implantable Down-Regulation Databases, Factual Cyclic N-Oxides Diagnosis, Differential Double-Blind Method Diabetes Mellitus, Type 2 Diabetes Complications Delivery of Health Care Data Collection Device Removal Coronary Stenosis Creatine Kinase Clopidogrel Clinical Trials, Phase II as Topic Clinical Trials, Phase III as Topic Costs and Cost Analysis Coronary Angiography Confounding Factors (Epidemiology) Comorbidity Communication Clinical Protocols Coronary Vessels Congresses as Topic Cohort Studies Combined Modality Therapy Coronary Artery Bypass, Off-Pump Confidence Intervals Coronary Disease Cells, Cultured Chronic Disease Cardiac Pacing, Artificial Carbazoles Cause of Death Chromatography, Liquid Cardiac Surgical Procedures Cardiac Catheterization Body Mass Index Blood Vessel Prosthesis Cardiovascular Agents Chi-Square Distribution Cardiotonic Agents Body Weight Brazil Cardiopulmonary Bypass Cerebrovascular Disorders Chest Pain Catheter Ablation Blotting, Western Blood Coagulation Tests Benzimidazoles beta-Alanine Animals Antibodies, Monoclonal Antithrombins Antithrombin III Aptamers, Nucleotide Blood Coagulation Arginine Blood Platelets Blood Pressure Blood Glucose Aspirin Anti-Arrhythmia Agents Angiotensin-Converting Enzyme Inhibitors Biological Markers Atrial Fibrillation Anastomosis, Surgical Amiodarone Angiotensin II Type 1 Receptor Blockers African Americans Angioplasty, Balloon, Coronary Age Factors Administration, Oral Algorithms Adult Adrenergic beta-Antagonists Adolescent Angiography Angina, Unstable Aged Aged, 80 and over Angiotensin Receptor Antagonists Acute Disease Age Distribution Academic Medical Centers Acute Coronary Syndrome Saphenous Vein Coronary Artery Bypass Coronary Artery Disease Anticoagulants Clinical Trials as Topic Japan Cardiovascular Diseases More